Application 205060

Type
NDA
Sponsor
ASTRAZENECA PHARMS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001EPANOVAOMEGA-3-CARBOXYLIC ACIDSCAPSULE;ORAL1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDSYesNo

Documents

DocumentSubmission typeDate
47548SUPPL2017-03-14
47521SUPPL2017-03-10
46928SUPPL2017-01-23
45608SUPPL2016-10-12
45524SUPPL2016-10-12
43483ORIG2016-03-28
32624ORIG2014-05-06
19618ORIG2014-05-06